Topiramate Tablet, Film Coated
Product Images NDC 82009-137

This text appears to be describing cumulative rates for time to first seizure for two different dosages of Topiramate (50 mg/day and 400 mg/day). The data is presented using numbers and a graph, with time (in days) on the x-axis and cumulative rates on the y-axis. The text also mentions a significant p-value of 0.0002, suggesting a statistically significant difference between the two dosages.*

Change From Baseline to Double-Blind Phase in Average Monthly Migraine Period Rate (+SE) for different doses of Topiramate and placebo. The text appears to be showing the number of participants in each group (N) and their respective doses of Topiramate. The study results indicate that there was a statistically significant improvement in migraine period rate for participants in the Topiramate groups compared to the placebo group. The p-values indicate the level of statistical significance for the observed differences.*

This text provides information about a medication called Topiramate. It is available in the form of tablets and each tablet contains 25 mg of Topiramate. The usual dosage is specified in the package insert, which should be consulted for complete prescribing information. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and protected from moisture. It is important to keep this medication and all drugs out of the reach of children. A Medication Guide is available on the website "quallentpharmaceuticals.com" or by calling 1-877-605-7243. The medication is manufactured by Zydus Lifesciences Ltd in India and is manufactured for Quallent Pharmaceuticals Health LLC, located in Grand Cayman, Cayman Islands.*

500 Tablets of Topiramate, USP are available with each tablet containing 50mg of the active ingredient. The usual dosage should be followed as per the instructions provided in the package insert for complete prescribing information. The tablets should be stored at a temperature of 20°C to 25°C (68°F to 77°F) and protected from moisture. They should be dispensed in a tightly sealed container and kept out of the reach of children. The medication guide can be accessed at www.qualentpharmaceuticals.com or by calling 1-877-605-7243. The tablets are manufactured by Zydus Lifesciences Ltd. in India and distributed by Quallent Pharmaceuticals Health LLC in the Grand Cayman, Cayman Islands.*

This text appears to be the description of a medication called Topiramate, available in tablet form. Each tablet contains 100 mg of Topiramate. The recommended dosage and complete prescribing information can be found in the package insert. The tablets should be stored at a temperature of 20°C to 25°C (68°F to 77°F) and protected from moisture in a tight container. It is important to keep this medication and all drugs out of the reach of children. A medication guide is available at www.quallenipharmaceuticals.com or by calling 1-877-605-7243. The medication is manufactured by Zydus Lifesciences Ltd in India and is distributed by Quallent Pharmaceuticals Health LLC located in Grand Cayman, Cayman Islands.*